Abstract
Objective In this study we explored how neuroimaging and blood biomarkers relate to cognitive recovery in traumatic brain injury (TBI) patients.
Methods Sixteen participants with moderate to severe traumatic brain injury (TBI) were enrolled, with blood samples, MRI, and diffusion tensor imaging (DTI) collected at enrollment and six months. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS), Disability Rating Scale, and Montreal Cognitive Assessment (MoCA) were also administered at both time points to evaluate neuropsychological and functional outcomes.
Results Fractional anisotropy (FA) in the genu (rs = 0.937, p = 0.002) and splenium of the corpus callosum (rs = 0.955, p < 0.001) was strongly correlated with changes in RBANS - Attention scores. Fornix FA was correlated with changes in RBANS - Total (rs = 0.928, p = 0.008), and left tapetum FA was correlated with changes in RBANS - Visuospatial scores (rs = 0.964, p < 0.001). Right temporal fusiform cortex grey matter (GM) volume was correlated with changes in RBANS - Attention scores (rs = 0.975, p = 0.005). Blood biomarkers did not show significance.
Conclusion Imaging markers like FA and GM volume appear to help predict cognitive recovery in TBI, supporting the potential use of neuroimaging to guide rehabilitation strategies.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the Norris Foundation
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB of Casa Colina Hospital and Centers for Healthcare gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
